Revatio Pfizer Inc. - Treatment for Pulmonary Arterial Hypertension
Revatio contains sildenafil citrate, the active ingredient in the erectile dysfunction medication Viagra. Revatio is indicated for the treatment of pulmonary arterial hypertension (PAH), a rare, aggressive and life-shortening vascular disease.Related Articles:
FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension - November 20, 2009
Pfizer Submits Regulatory Filings for Revatio as a Treatment for Pulmonary Arterial Hypertension - December 3, 2004
FDA Drug Approvals Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Aug | Oct | Dec
